Tevogen Bio Holdings Inc. ($TVGN)
Filing Information
| Accession Number | 0001123292-26-000465 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 17, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
972
Total Value
$6,635.17
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer, Global R&D Lead.
All holdings herein have been adjusted to reflect the Company's 1-for-50 reverse stock split effected on March 6, 2026. | Common Stock | โ | Mar 10, 2026 | Sale | 19 | $7.75 | $147.25 | 77,893 | Direct | โ | View Details | |
Chief Scientific Officer, Global R&D Lead.
All holdings herein have been adjusted to reflect the Company's 1-for-50 reverse stock split effected on March 6, 2026. | Common Stock | โ | Mar 11, 2026 | Sale | 452 | $7.26 | $3,281.52 | 77,441 | Direct | โ | View Details | |
Chief Scientific Officer, Global R&D Lead.
All holdings herein have been adjusted to reflect the Company's 1-for-50 reverse stock split effected on March 6, 2026. | Common Stock | โ | Mar 13, 2026 | Sale | 501 | $6.40 | $3,206.40 | 76,940 | Direct | โ | View Details |